Monocyte-induced downregulation of nitric oxide synthase in cultured aortic endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 9, 1996, Pages 1095-1103

  Marczin, Nándor ^a   Antonov, Alexander ^a   Papapetropoulos, Andreas ^a   Munn, David H ^a   Virmani, Renu ^b   Kolodgie, Frank D ^b   Gerrity, Ross ^c   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c NONE

Author keywords

atherosclerosis; cGMP; endothelium derived relaxing factor; interleukin 1; nitric oxide synthase

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; CATALASE; COLONY STIMULATING FACTOR 1; CYCLIC GMP; CYTOKINE; ENDOTHELIUM DERIVED RELAXING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; TIRON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; MONOLAYER CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029763252     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.9.1095     Document Type: Article

References (41)

1. Rubanyi GM. Endotheliurn-derived vasoactive factors in health and disease. In: Rubanyi GM, ed. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Mt Kisco, NY: Futura Publishing Co; 1991:xi-xix.
2. Davies PF. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest. 1986;55:5-24.
3. Campbell JH, Campbell GR. Endothelial influences on vascular smooth muscle phenotype. Annu Rev Physiol. 1986;48:295-306
4. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
5. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
6. Ignarro LJ. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension. 1990;16:477-483.
7. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988;94:1020-1022.
8. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
9. Tolins JP, Palmer RMJ, Moncada S, Raij L. Role of endothelium-derived relaxing factor in the regulation of renal hemodynamic response. Am J Physiol. 1990;258:H655-H662.
10. May GR, Crook P, Moore PK, Page CP. The role of nitric oxide as endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol. 1991;102: 759-763.
11. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
12. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y. Antiproliferative action of cGMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis. 1989;80:143-147.
13. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol. 1990;189:347-353.
14. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
15. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Inhibition of nitric oxide increases neointima in cholesterol-fed rabbits. Circulation. 1993;88(suppl I):I-366. Abstract.
16. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the lesions of atherosclerosis. Science. 1973;180:1332-1339.
17. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
18. Harrison DG, Minor RL, Guerra R, Quillen JE, Sellke FW. Endothelial dysfunction in atherosclerosis. In: Rubanyi GM, ed. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Mt Kisco, NY: Futura Publishing Co; 1991:263.
19. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endotheliurn-dependent relaxation in rabbit aorta. Nature. 1987;327:237-239.
20. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in the heritable hyperlipidemic rabbits. Circ Res. 1991;68:330-337.
21. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992;89: 10-18.
22. Galle J, Mülsch A, Busse R, Bassenge E. Effects of native and oxidized low-density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 1991;11: 198-203.
23. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989;79:287-291.
24. Yasue H, Matsuyama Koshi, Matsuyama Kozaburo, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482-490.
25. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
26. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
27. Hakkert BC, Rentenaar JM, Van Mourik JA. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types. Br J Haematol. 1992;80:495-503.
28. Lefer AM, Ma X-L. Cytokines and growth factors in endothelial dysfunction. Crit Care Med. 1993;21:S9-S14.
29. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee M-E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
30. Antonov AS, Nikolaeva MA, Klueva TS, Romanov YA, Babaev VR, Bystrevskaya VB, Perov NA, Repin VS, Smirnov VN. Primary culture of endothelial cells from atherosclerotic human aorta, I: identification, morphological and ultrastructural characteristics of two endothelial subpopulations. Atherosclerosis. 1986; 59:1-19.
31. Antonov AS, Lukashev ME, Romanov YA, Tkachuk VA, Repin V, Smirnov VN. Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol esters PMA: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A. 1986; 83:9704-9708.
32. Shyrinsky VP, Antonov AS, Birukov KG, Sobolevsky AV, Romanov YA, Kabaeva NV, Antonova GN, Smirnov VN. Prothrombotic phenotype diversity of human aortic endothelial cells in culture. J Cell Biol. 1989;109:331-339.
33. Marczin N, Papapetropoulos A, Jilling T, Catravas JD. Tyrosine kinase inhibitors suppress endotoxin- and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am J Physiol. 1993;265:H1014-H1018.
34. Gerrity RG, Goss JA, Soby L. Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis. 1985;5:55-66.
35. Marczin N, Ryan US, Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells, in culture. Circ Res. 1992;70:326-340.
36. Marczin N, Catravas JD. Basal release of EDRF under conditions of oxidant stress. In: Catravas JD, Callow AD, Gillis CN, Ryan US, eds. Vascular Endothelium; Physiological Basis of Clinical Problems II. New York, NY: Plenum Press; 1993:3-16.
37. Papapetropoulos A, Antonov A, Vermani R, Kolodgie FD, Munn D, Marczin N, Ryan JW, Gerrity RG, Catravas JD. Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cells. Circ Res. 1996;79. In press.
38. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion plays a role in the breakdown of EDRF. Nature. 1986;320:454-456.
39. Munn DH, Armstrong E. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon. Cancer Res. 1993;53:2603-2613.
40. Dukes CS, Matthews TJ, Weinberg JB. Human immunodeficiency virus type 1 infection of human monocytes and macrophages does not alter their ability to generate an oxidative burst. J Infect Dis. 1993;168:459-462.
41. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 1994;93:2236-2243.